Sterility, sterilisation and sterility assurance for pharmaceuticals : technology, validation and current regulations / Tim Sandle
Failure to adequately control any microbial challenge associated within process or product by robust sterilisation will result in a contaminated marketed product, with potential harm to the patient. Sterilisation is therefore of great importance to healthcare and the manufacturers of medical devices and pharmaceuticals. Sterility, sterilisation and sterility assurance for pharmaceuticals examines different means of rendering a product sterile by providing an overview of sterilisation methods including heat, radiation and filtration. The book outlines and discusses sterilisation technology and.
| Medienart: |
Buch |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
Oxford u.a. Woodhead Publ.: 2013 |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sandle, Tim [VerfasserIn] |
|---|
| Links: |
|---|
| ISBN: |
|---|
| Nlm: |
2014 A-401 WA 240 |
|---|---|
| BKL: | |
| Themen: |
Drugs |
| Anmerkungen: |
With bibliographical references and index |
|---|
| Umfang: |
XXX, 339 S. ; Ill., graph. Darst. ; 24 cm |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
778660524 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 778660524 | ||
| 003 | DE-627 | ||
| 005 | 20230905071842.0 | ||
| 007 | tu | ||
| 008 | 140218s2013 xxk||||| 00| ||eng c | ||
| 010 | |a 2013944155 | ||
| 020 | |a 9781907568381 |c hbk. : ca. USD 240.00 |9 978-1-907568-38-1 | ||
| 035 | |a (DE-627)778660524 | ||
| 035 | |a (DE-599)GBV778660524 | ||
| 035 | |a (OCoLC)834416834 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XA-GB |c XD-US |c XB-IN | ||
| 050 | 0 | |a RS199.S73 | |
| 060 | 0 | |a 2014 A-401 | |
| 060 | 0 | |a WA 240 | |
| 082 | 0 | |a 615.1 |q LOC |2 23 | |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a 58.28 |2 bkl | ||
| 100 | 1 | |a Sandle, Tim |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sterility, sterilisation and sterility assurance for pharmaceuticals |b technology, validation and current regulations |c Tim Sandle |
| 264 | 1 | |a Oxford [u.a.] Woodhead Publ. |c 2013 | |
| 300 | |a XXX, 339 S. |b Ill., graph. Darst. |c 24 cm | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 490 | 1 | |a Woodhead Publishing series in biomedicine |v 32 | |
| 500 | |a With bibliographical references and index | ||
| 520 | |a Failure to adequately control any microbial challenge associated within process or product by robust sterilisation will result in a contaminated marketed product, with potential harm to the patient. Sterilisation is therefore of great importance to healthcare and the manufacturers of medical devices and pharmaceuticals. Sterility, sterilisation and sterility assurance for pharmaceuticals examines different means of rendering a product sterile by providing an overview of sterilisation methods including heat, radiation and filtration. The book outlines and discusses sterilisation technology and | ||
| 650 | 0 | |a Drugs |x Sterilization | |
| 650 | 2 | |a Sterilization |x methods | |
| 650 | 2 | |a Technology, Pharmaceutical | |
| 689 | 0 | 0 | |D s |0 (DE-588)4295343-1 |0 (DE-627)104175435 |0 (DE-576)210969113 |a Sterilität |g Hygiene |2 gnd |
| 689 | 0 | 1 | |D s |0 (DE-588)4045699-7 |0 (DE-627)104162406 |0 (DE-576)209066407 |a Pharmazeutische Technologie |2 gnd |
| 689 | 0 | |5 (DE-627) | |
| 776 | 1 | |z 9781908818638 |c (eBook) | |
| 830 | 0 | |a Woodhead Publishing series in biomedicine |v 32 |9 32 |w (DE-627)73979986X |w (DE-576)378222414 |w (DE-600)2709620-8 |x 2050-0289 |7 ns | |
| 856 | 4 | 2 | |u http://www.gbv.de/dms/bs/toc/778660524.pdf |m V:DE-601 |m B:DE-84 |q pdf/application |v 2014-03-24 |x Verlag |y Inhaltsverzeichnis |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |u http://www.loc.gov/catdir/enhancements/fy1512/2013944155-d.html |v 2015-08-31 |x Verlag |3 Verlagsangaben |
| 912 | |a GBV_ILN_20 | ||
| 912 | |a ISIL_DE-84 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-DE-84 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a ISIL_DE-89 | ||
| 936 | b | k | |a 58.28 |j Pharmazeutische Technologie |0 (DE-627)106417622 |
| 951 | |a BO | ||
| 953 | |2 045F |a 615.1 | ||
| 980 | |2 20 |1 01 |x 0084 |b 1458103331 |c 00 |f LS2 |d PM C 779 |e --%%-- |j --%%-- |c 09 |f --%%-- |d 2931-5378 |e --%%-- |j --%%-- |y k |z 10-03-14 | ||
| 980 | |2 70 |1 01 |x 0089 |b 1517809517 |c 00 |f --%%-- |d RT 2211(32) |e u |j --%%-- |y z |z 24-02-15 | ||
| 984 | |2 20 |1 01 |x 0084 |a 84$029315378 | ||
| 984 | |2 70 |1 01 |x 0089 |a 89$13831876X | ||